Images List Premium Download Classic

G Proteins

G Proteins-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Markers and therapeutic indicators for glioblastoma multiforme (gbm)
Institute For Systems Biology
June 22, 2017 - N°20170176439

A signature of proteins occurring in glioblastoma multiforme (gbm) tissue comprised of 33 cell surface proteins (gbmsig) that distinguish subjects with gbm from healthy controls with more than 98% accuracy is described. In addition, four of the members of this signature are particularly useful as blood-borne markers of gbm. Certain other members of the signature are indicators of the possible efficacy of ...
Emulsion chemistry for encapsulated droplets
Bio-rad Laboratories, Inc.
June 22, 2017 - N°20170175179

System, including methods, apparatus, compositions, and kits, for making and using a stabilized emulsion. A method of generating a stabilized emulsion is provided. In the method, an aqueous phase may be provided. The aqueous phase may include an effective concentration of one or more skin-forming proteins. An emulsion may be formed. The emulsion may include droplets of a dispersed phase ...
Methods of treating nail and scalp psoriasis
Kirin-amgen, Inc.
June 22, 2017 - N°20170174772

The present invention relates to a therapeutic agent for nail and scalp psoriasis comprising an il-17 receptor a (il-17ra or il-17r) antigen binding proteins, such as monoclonal antibodies that bind il-17ra, and method of using the same.
G Proteins Patent Pack
Download 271+ patent application PDFs
G Proteins Patent Applications
Download 271+ G Proteins-related PDFs
For professional research & prior art discovery
inventor
  • 271+ full patent PDF documents of G Proteins-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel binding proteins for pcsk9
Daiichi Sankyo Co., Ltd.
June 22, 2017 - N°20170173112

The present disclosure relates to novel lipocalin muteins which bind to pcsk9. The disclosure also provides corresponding nucleic acid molecules encoding lipocalin muteins and methods for producing lipocalin muteins as well as their encoding nucleic acid molecules.
Oligosaccharide modification and labeling of proteins
Life Technologies Corporation
June 15, 2017 - N°20170166943

The present invention generally relates to methods of functionalizing proteins, particularly antibodies, at oligosaccharide linkages, methods of humanizing antibodies by modifying glycosylation, as well as to novel antibodies linked to modified oligosaccharides. The invention further relates to kits that may be used to produce the antibodies of the invention.
Inducible dna binding proteins and genome perturbation tools and applications thereof
President And Fellows Of Harvard College
June 15, 2017 - N°20170166903

The present invention generally relates to methods and compositions used for the spatial and temporal control of gene expression that may use inducible transcriptional effectors. The invention particularly relates to inducible methods of altering or perturbing expression of a genomic locus of interest in a cell wherein the genomic locus may be contacted with a non-naturally occurring or engineered composition ...
G Proteins Patent Pack
Download 271+ patent application PDFs
G Proteins Patent Applications
Download 271+ G Proteins-related PDFs
For professional research & prior art discovery
inventor
  • 271+ full patent PDF documents of G Proteins-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Bcma antigen binding proteins
Amgen Inc.
June 15, 2017 - N°20170165373

The present invention relates to bcma (b-cell maturation antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to bcma antibody drug conjugates.
Anti-tigit antigen-binding proteins and methods of use thereof
Potenza Therapeutics, Inc.
June 15, 2017 - N°20170165366

Provided herein are antigen-binding proteins (abps) that selectively bind to tigit and its isoforms and homologs, and compositions comprising the abps. Also provided are methods of using the abps, such as therapeutic and diagnostic methods.
Methods and compositions for detection of analytes
T2 Biosystems, Inc.
June 08, 2017 - N°20170159113

The present invention relates to methods and compositions for detecting analytes, including proteins, polysaccharides, viruses, nucleic acids and cells. The methods and compositions utilize a reporter probe, suitably a multivalent reporter probe, to detect the presence of the analytes. In embodiments, the methods and compositions can be used for non-enzymatic detection of nucleic acids.
Cell free translation system for compound screening and related uses
Prosetta Antiviral Inc.
June 08, 2017 - N°20170159097

The invention provides a cell-free system comprising not more than about 5% wheat germ extract for expressing proteins such as viral proteins and proteins required for viral capsid assembly, and proteins that assemble into multiprotein complexes in a manner analogous to viral capsids, are provided. Further provided are methods for expressing proteins such as viral proteins, proteins required for capsid assembly, ...
Recombinant microorganisms for the enhanced production of mevalonate, isoprene, isoprenoid precursors, isoprenoids, and acetyl-coa-derived products
Danisco Us Inc.
June 08, 2017 - N°20170159074

The invention features compositions and methods for the increased production of mevalonate, isoprene, isoprenoid precursor molecules, isoprenoids, and/or acetyl-coa-derived products in recombinant microorganisms by engineering the microorganisms to comprise one or more acetylating proteins such that the expression and/or activity of the one or more acetylating proteins is modulated.
Engineered nucleic acid-targeting nucleic acids
Caribou Biosciences, Inc.
June 08, 2017 - N°20170159073

The present disclosure provides engineered polynucleotide sequences that form scaffolds and nucleoprotein complexes comprising such engineered polynucleotide sequences that form scaffolds and nucleic acid binding proteins. Nucleic acid sequences encoding the engineered polynucleotide sequences that form scaffolds, as well as expression cassettes, vectors and cells comprising such polynucleotide sequences, are described. A variety of methods for making and using the ...
Caninized anti-ngf antibodies and methods thereof
Zoetis Services Llc
June 08, 2017 - N°20170158756

The invention provides novel caninized anti-ngf antibodies (such as caninized anti-ngf antagonist antibodies and antigen binding proteins), and polynucleotides encoding the same. The invention further provides use of said antibodies or antigen binding proteins and/or nucleotides in the treatment and/or prevention of ngf related disorders, particularly pain.
G Proteins Patent Pack
Download 271+ patent application PDFs
G Proteins Patent Applications
Download 271+ G Proteins-related PDFs
For professional research & prior art discovery
inventor
  • 271+ full patent PDF documents of G Proteins-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Use of an anthranilic diamide derivatives with heteroaromatic and heterocyclic substituents in combination with a ...
Zoetis Services Llc
June 08, 2017 - N°20170156328

In which r1, r2, r3, r4, r5, r6, a, q and n can have the definitions stated in the description, and at least one biological control agent selected from bacteria, fungi or yeasts, protozoas, viruses, entomopathogenic nematodes, and botanical extracts, or products produced by microorganisms including proteins or secondary metabolites, and optionally an inoculant, for reducing overall damage of plants ...
Methods of polypeptide identification, and compositions therefor
Washington University
June 01, 2017 - N°20170153243

Methods are disclosed for identifying one or more proteins or polypeptides comprised by a sample. The methods comprise determining binding of each polypeptide with respect to each binding pool of a plurality of binding pools, wherein each binding pool comprises one or more probes which bind a structure comprised by a protein or polypeptide. In some aspects, polypeptides can be ...
Molecular analysis using micro electro-mechanical sensor devices
Nevada Nanotech Systems Inc.
June 01, 2017 - N°20170153193

Analysis instruments and sensors, particularly micro-electro mechanical sensor (mems) devices, for molecular analysis of chemicals and other materials, including, for example, polymers, drugs, nanomaterials, biological samples including proteins, and environmental samples including water suspected of contamination, and the like in vapor, liquid, and/or solid form.
Engineered co2-fixing chemotrophic microorganisms producing carbon-based products and methods of using the same
Kiverdi, Inc.
June 01, 2017 - N°20170152533

Disclosed herein are microorganisms containing exogenous or heterologous nucleic acid sequences, wherein the microorganisms are capable of growing on gaseous carbon dioxide, gaseous hydrogen, syngas, or combinations thereof. In some embodiments the microorganisms are chemotrophic bacteria that produce or secrete at least 10% of lipid by weight. Also disclosed are methods of fixing gaseous carbon into organic carbon molecules useful for ...
Methods and products for transfecting cells
Factor Bioscience Inc.
June 01, 2017 - N°20170152483

The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins ...
Antigen binding proteins to oncostatin m (osm)
Glaxo Group Limited
June 01, 2017 - N°20170152312

The present invention concerns antigen binding proteins and fragments thereof which specifically bind oncostatin m (osm), particularly human osm (hosm) and which inhibit the binding of osm to the gp130 receptor but does not directly interact with site ii residues. The invention also concerns a method of humanising antibodies. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.
Human fgfr2b extracellular domain and nucleic acid for coding same
Guangzhou Shenglu Biotech Limited Company
June 01, 2017 - N°20170152299

Provided are wild-type, s252w mutant-type, and p253r mutant-type fgfr2b extracellular segments and truncated proteins thereof, coding genes of the foregoing proteins, a recombinant vector comprising the genes, a host cell, a method for preparing the proteins, and a fusion protein of the proteins and an fc segment. Also provided are applications of the proteins and a composition ...
Myostatin inhibition for enhancing muscle and/or improving muscle function
Nationwide Children's Hospital
June 01, 2017 - N°20170151348

The present invention relates to methods for inhibitiing myostatin, a regulator of muscle mass, for muscle enhancement (including inducing hypertrophy and/or hyperplasia) as well as improving muscle function (including decreasing atrophy and/or increasing endurance, force and/or strength). Some of the methods involve delivering genes to cells using gene delivery or other delivery techniques known in the art ...
Loading